Symptoms often include facial pressure, congestion and fatigue — It affects about 37 million Americans each year — Infections ...

A systematic review found improved sleep quality and longer REM sleep after endoscopic surgery for chronic rhinosinusitis ...

Please provide your email address to receive an email when new articles are posted on . The analysis compared results from the WAYPOINT, SINUS-52 and SYNAPSE studies. Tezepelumab outperformed ...

(Alliance News) - GSK PLC on Tuesday said depemokimab, sold under the brand name Exdensur, has been approved by Japan's Ministry of Health, Labour and Welfare for severe asthma and chronic ...

Insmed Inc. shares sunk in late trading Wednesday after the company said its drug to treat a sinus condition failed in a mid-stage trial — a rare setback for the fast-growing biotech.

Dupilumab, a fully human monoclonal antibody, inhibits the signaling of the interleukin 4 (IL-4) and IL-13 pathways.

Treatments known as biologics - which work by switching off the immune system reaction that drives inflammation - are on the ...

Know when inhalers actually help blocked nose relief, when they can worsen congestion, and common mistakes doctors warn against for safer breathing.

Insmed subsequently decided to discontinue the program with immediate effect. ・The company also announced that it has acquired a new experimental drug called INS1148. ・The new drug adds to the company ...

Investing.com -- China has approved GSK Plc ’s (LON:GSK) Nucala as an add-on maintenance treatment for adults with chronic ...

GSK plc (NYSE:GSK) is included among the 15 Global Dividend Stocks to Diversify Your Portfolio. On December 10, HSBC analyst ...

Brits are being urged to check the colour of their snot as the new H3N2 subclade K flu spreads, with experts revealing said ...